You are here:
The latest news and updates related to the pneumococcal Advance Market Commitment.
10 September 2010
Pfizer vaccine receives AMC approval
The AMC Secretariat announces that the Independent Assessment Committee of the Advance Market Commitment (AMC) for pneumococcal disease has approved Pfizer's pneumococcal vaccine Prevenar 13, as eligible for purchase to the AMC terms and conditions.
04 March 2010
Conference on Innovative Financial Solutions for Development
IFFIm and AMC are considered the "most encouraging" examples of innovative thinking in development at the Marketplace for Innovative Financial Solutions in Paris.
12 October 2009
Pneumococcal AMC receives offers
The AMC Secretariat announces four suppliers have made offers to supply vaccines under the Pneumococcal Advance Market Commitment.
30 September 2009
New registered manufacturer is publicly announced
With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate Panacea Biotect Ltd and the Serum institute of India are two of the companies that have begun the registration process in order to partici
23 September 2009
Manufacturers register to participate in the Pneumococcal AMC
With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate.
12 June 2009
GAVI partners fulfil promise
The GAVI Alliance partners, the World Bank, WHO and UNICEF, and five national governments and the Bill & Melinda Gates Foundation today formally kicked-off the first-ever Advance Market Commitment (AMC) designed to accelerate access to vaccines against pneumococcal disease.
01 June 2008
Pilot AMC for pneumococcal disease
To accelerate the development and availability of new vaccines against pneumococcal disease, Italy, the UK, Canada, Norway, Russia, and the Bill & Melinda Gates Foundation together committed US$ 1.5 billion to finance a pilot Advance Market Commitment (AMC).
01 May 2008
Optimal terms for a pilot AMC
Input from developing countries, industry, civil society organisations and donors are being considered in determining the optimal terms for a pilot AMC.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2017
modal window here